Applied Graphene Materials plc (APGMF)
USD 0.0
(-99.6%)
USD 0.0
(-99.6%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 123 Thousand | 83 Thousand | 50 Thousand | 77 Thousand | 97 Thousand | 75 Thousand |
| Cost of Revenue | 363 Thousand | 215 Thousand | 472 Thousand | 250 Thousand | 385 Thousand | 397 Thousand |
| Gross Profit | -240 Thousand | -132 Thousand | -422 Thousand | -173 Thousand | -288 Thousand | -322 Thousand |
| Operating Expenses | 3.31 Million | 3.56 Million | 4.48 Million | 4.42 Million | 4.02 Million | 4.25 Million |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.31 Million | - | - | - | - | - |
| Cost and Expenses | 3.68 Million | 3.78 Million | 4.95 Million | 4.67 Million | 4.4 Million | 4.64 Million |
| Operating Income | -3.55 Million | -3.69 Million | -4.9 Million | -4.6 Million | -4.31 Million | -4.57 Million |
| Interest Expense | 9000.00 | 8000.00 | - | - | - | - |
| Income Tax Expense | -391 Thousand | -476 Thousand | -908 Thousand | -1.04 Million | -1.23 Million | -175 Thousand |
| Earnings before Tax | -3.56 Million | -3.66 Million | -4.83 Million | -4.54 Million | -4.27 Million | -4.51 Million |
| Net Income | -3.17 Million | -3.18 Million | -3.92 Million | -3.49 Million | -3.04 Million | -4.34 Million |
| Earnings Per Share Basic | -0.06 | -0.06 | -0.08 | -0.08 | -0.14 | -0.22 |
| Earnings Per Share Diluted | -0.06 | -0.06 | -0.08 | -0.08 | -0.13 | -0.21 |
| Weighted Average Shares Outstanding | 56.4 Million | 49.4 Million | 49.4 Million | 42.7 Million | 22.1 Million | 19.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.4 Million | 49.4 Million | 49.4 Million | 43.6 Million | 23 Million | 20.9 Million |
| Gross Margin | -1.95 | -1.59 | -8.44 | -2.25 | -2.97 | -4.29 |
| EBIT Margin | -22.26 | -33.31 | -84.32 | -51.69 | -41.85 | -58.73 |
| Profit Margin | -25.80 | -38.42 | -78.54 | -45.44 | -31.37 | -57.92 |
| EBITDA | -3.14 Million | -3.21 Million | -4.21 Million | -3.98 Million | -3.8 Million | -4.4 Million |
| Earnings Before Tax Margin | -28.93 | -44.55 | -98.04 | -59.77 | -44.43 | -60.99 |
| Breakdown | 2023 Q4 | 2023 Q2 | 2022 Q2 | 2021 FY | 2021 Q4 | 2021 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 62.49 Thousand | 123 Thousand | 112.7 Thousand | 55.49 Thousand |
| Cost of Revenue | - | - | 626.27 Thousand | 363 Thousand | 573.25 Thousand | 475.69 Thousand |
| Gross Profit | - | - | -563.78 Thousand | -240 Thousand | -460.54 Thousand | -420.19 Thousand |
| Operating Expenses | - | - | 2.02 Million | 3.31 Million | 1.99 Million | 1.94 Million |
| Selling, General and Administrative Expenses | - | - | 2.02 Million | - | 1.99 Million | 1.94 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | 2.65 Million | 3.68 Million | 2.57 Million | 2.42 Million |
| Operating Income | - | - | -2.58 Million | -3.55 Million | -2.45 Million | -2.36 Million |
| Interest Expense | - | - | - | 9000.00 | 5565.54 | 2642.74 |
| Income Tax Expense | - | - | -281.21 Thousand | -391 Thousand | -296.36 Thousand | -235.2 Thousand |
| Earnings before Tax | - | - | -2.58 Million | -3.56 Million | -2.46 Million | -2.37 Million |
| Net Income | - | - | -2.3 Million | -3.17 Million | -2.16 Million | -2.13 Million |
| Earnings Per Share Basic | - | - | -0.04 | - | -0.03 | -0.04 |
| Earnings Per Share Diluted | - | - | -0.04 | - | -0.03 | -0.04 |
| Weighted Average Shares Outstanding | - | - | 64.3 Million | 56.4 Million | 64.33 Million | 49.6 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | 64.3 Million | 56.4 Million | 64.33 Million | 49.6 Million |
| Gross Margin | - | - | -9.02 | -1.95 | -4.09 | -7.57 |
| EBIT Margin | - | - | -37.46 | - | -19.41 | -37.57 |
| Profit Margin | - | - | -36.94 | -25.80 | -19.23 | -38.48 |
| EBITDA | - | - | -2.34 Million | - | -2.18 Million | -2.08 Million |
| Earnings Before Tax Margin | - | - | -41.44 | -28.93 | -21.81 | -42.67 |
AJANTPHARM
SMAYF
SHO
JNVR
TTNDF
ROI